Vaccination Trial of a Recombinant MVA-BN-WEV Vaccine in Healthy Adult Subjects

NCT04131595 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

45

Enrollment

INDUSTRY

Sponsor class

Conditions

Equine Encephalitis

Interventions

BIOLOGICAL: MVA-BN-WEV Dose 1
BIOLOGICAL: MVA-BN-WEV Dose 2
BIOLOGICAL: MVA-BN-WEV Dose 3

Sponsor

Bavarian Nordic

Collaborators

[object Object]